Angiogenesis related abnormalities underlie several life-threatening disorders. Despite approved therapies, scientists have yet to develop highly efficient, low cost approaches with minimal side effects.
We evaluated the antiangiogenic activity of 50% hydroalcoholic extracts of Pergularia tomentosa L. root and aerial parts along with their EtOAc and water fractions, in vivo and in vitro. Transgenic zebrafish line Tg(fli1:EGFP) was used for in vivo assay and human umbilical vein endothelial cell (HUVEC) migration test along with possibility of tube formation were performed as in vitro tests. Furthermore, microvasculature in chicken chorioallantoic membrane (CAM) was assessed under P. tomentosa treatment. The fractionation of the 50% hydroalcoholic extracts was led to the identification of the best active fraction in this study. The metabolite profiling of the active fraction was also carried out using LC-HRESIMS analysis.
Pergularia tomentosa markedly inhibited intersegmental vessel (ISV) formation at 48 h post-fertilization (hpf) embryos in zebrafish. The water fraction of root hydroalcoholic extract (PtR2), showed strong antiangiogenic effect with minimal adverse viability impacts. Over 80% of embryos showed more than 50% inhibition in their ISV development at 20 and 40 μg/mL. PtR2 at 20 μg/mL substantially reduced human umbilical vein endothelial cell (HUVEC) migration up to 40%, considerable destruction of the formed tubes in the tube formation and microvasculature in CAM assays. Immunocytochemistry showed a marked reduction in vascular endothelial cadherin (VE-cadherin) abundance at cell junctions concurrent with substantial reduction of phospho-Akt (p-Akt) and β-catenin protein expressions. Phytochemical profile of PtR2 showed a rich source of cardenolide structures, including ghalakinoside, calactin and calotropin derivatives.
Thus, the P. tomentosa cardenolide-rich fraction (PtR2) may hold a considerable promise for an antiangiogenic impact by impairment of endothelial cell (EC) migration and viability.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Acetylated low-density lipoprotein
Human umbilical vein endothelial cells
LC coupled to electrospray ionization and high resolution mass spectrometry
Vascular endothelial cadherin
Vascular endothelial growth factor
Chung AS, Ferrara N. Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol. 2011;27:563–84. https://doi.org/10.1146/annurev-cellbio-092910-154002.
Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell. 2011;146(6):873–87. https://doi.org/10.1016/j.cell.2011.08.039.
Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov. 2007;6(4):273–86. https://doi.org/10.1038/nrd2115.
Dai F, Gao L, Zhao Y, Wang C, Xie S. Farrerol inhibited angiogenesis through Akt/mTOR, Erk and Jak2/Stat3 signal pathway. Phytomedicine. 2016;23(7):686–93. https://doi.org/10.1016/j.phymed.2016.03.008.
Zhang HZ, Li CY, Wu JQ, Wang RX, Wei P, Liu MH, et al. Anti-angiogenic activity of Para-coumaric acid methyl ester on HUVECs in vitro and zebrafish in vivo. Phytomedicine. 2018;48:10–20. https://doi.org/10.1016/j.phymed.2018.04.056.
Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK, et al. Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol. 2015;35(Suppl):S224–S43. https://doi.org/10.1016/j.semcancer.2015.01.001.
Hammiche V, Maiza K. Traditional medicine in Central Sahara: pharmacopoeia of Tassili N’ajjer. J Ethnopharmacol. 2006;105(3):358–67.
Al-Said MS, Kadertaragan AHU, Hifnawy MS. Pharmacognostical and preliminary phytochemical investigation of the fruit of Pergularia tomentosa L. Int J Crude Drug Res. 1988;26(1):9–16. https://doi.org/10.3109/13880208809053882.
Babaamer Z, Sekhri L, Al-Jaber H, Al-Qudah M, Abu ZM. Extraction and identification of triterpenoids from Pergularia tomentosa L. Ḥawliyāt al-‘Ulūm wa-al-Tiknūlūjiyā. 2013;281(1764):1–10.
Hussein HI, Al-Rajhy D, El-Shahawi FI, Hashem S. Molluscicidal activity of Pergularia tomentosa (L.), methomyl and methiocarb, against land snails. Int J Pest Manag. 1999;45(3):211–3.
Green PW, Veitch NC, Stevenson PC, Simmonds MS. Cardenolides from Gomphocarpus sinaicus and Pergularia tomentosa (Apocynaceae: Asclepiadoideae) deter the feeding of Spodoptera littoralis. Arthropod Plant Interact. 2011;5(3):219–25.
Piacente S, Masullo M, De Nève N, Dewelle J, Hamed A, Kiss R, et al. Cardenolides from Pergularia tomentosa display cytotoxic activity resulting from their potent inhibition of Na+/K+-ATPase. J Nat Prod. 2009;72(6):1087–91.
Yakubu R, Jibril F, Lukman A, Sheikh F. Trends for antioxidant power of phytochemicals from Pergularia tomentosa L.(Asclepiadacea) whole plant. Scholars Academic J Pharm. 2015;4(2):74–80.
Bekheet SH, Abdel-Motaal FF, Mahalel UA. Antifungal effects of Ficus sycomorus and Pergularia tomentosa aqueous extracts on some organs in Bufo regularis treated with Aspergillus Niger. Tissue Cell. 2011;43(6):398–404.
Hosseini SH, Masullo M, Cerulli A, Martucciello S, Ayyari M, Pizza C, et al. Antiproliferative Cardenolides from the aerial parts of Pergularia tomentosa. J Nat Prod. 2019;82(1):74–9. https://doi.org/10.1021/acs.jnatprod.8b00630.
Hamed AI, Plaza A, Balestrieri ML, Mahalel UA, Springuel IV, Oleszek W, et al. Cardenolide glycosides from Pergularia tomentosa and their proapoptotic activity in Kaposi's sarcoma cells. J Nat Prod. 2006;69(9):1319–22.
Petschenka G, Fei CS, Araya JJ, Schroder S, Timmermann BN, Agrawal AA. Relative selectivity of plant Cardenolides for Na(+)/K(+)-ATPases from the monarch butterfly and non-resistant insects. Front Plant Sci. 2018;9:1424. https://doi.org/10.3389/fpls.2018.01424.
Agrawal AA, Petschenka G, Bingham RA, Weber MG, Rasmann S. Toxic cardenolides: chemical ecology and coevolution of specialized plant-herbivore interactions. New Phytol. 2012;194(1):28–45. https://doi.org/10.1111/j.1469-8137.2011.04049.x.
Pongrakhananon V. Anticancer properties of cardiac glycosides. Cancer Treatment—Conventional and Innovative Approaches Intech 2013:65–83.
Yu Y, Chen R, Sun Y, Pan Y, Tang W, Zhang S, et al. Manipulation of VEGF-induced angiogenesis by 2-N, 6-O-sulfated chitosan. Acta Biomater. 2018;71:510–21. https://doi.org/10.1016/j.actbio.2018.02.031.
Bentley K, Franco CA, Philippides A, Blanco R, Dierkes M, Gebala V, et al. The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis. Nat Cell Biol. 2014;16(4):309–21. https://doi.org/10.1038/ncb2926.
Yamamoto H, Ehling M, Kato K, Kanai K, van Lessen M, Frye M, et al. Integrin beta1 controls VE-cadherin localization and blood vessel stability. Nat Commun. 2015;6:6429. https://doi.org/10.1038/ncomms7429.
Ramu A, Kathiresan S, Ali AB. Gramine inhibits angiogenesis and induces apoptosis via modulation of TGF-beta signalling in 7,12 dimethylbenz[a]anthracene (DMBA) induced hamster buccal pouch carcinoma. Phytomedicine. 2017;33:69–76. https://doi.org/10.1016/j.phymed.2017.05.008.
Yang CY, Chen C, Lin CY, Chen YH, Lin CY, Chi CW, et al. Garcimultiflorone K inhibits angiogenesis through Akt/eNOS- and mTOR-dependent pathways in human endothelial progenitor cells. Phytomedicine. 2019;64:152911. https://doi.org/10.1016/j.phymed.2019.152911.
al-Said MS, Abu-Jayyab A, Hifnawy MS. Biochemical studies on ghalakinoside, a possible antitumor agent from Pergularia tomentosa. J Ethnopharmacol. 1989;27(1–2):235–40.
Hamed AI, Plaza A, Balestrieri ML, Mahalel UA, Springuel IV, Oleszek W, et al. Cardenolide glycosides from Pergularia tomentosa and their proapoptotic activity in Kaposi's sarcoma cells. J Nat Prod. 2006;69(9):1319–22. https://doi.org/10.1021/np060228l.
Liang F, Han Y, Gao H, Xin S, Chen S, Wang N, et al. Kaempferol identified by Zebrafish assay and fine fractionations strategy from Dysosma versipellis inhibits angiogenesis through VEGF and FGF pathways. Sci Rep. 2015;5:14468. https://doi.org/10.1038/srep14468.
Vestweber D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol. 2008;28(2):223–32. https://doi.org/10.1161/ATVBAHA.107.158014.
Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, Bono F, et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell. 1999;98(2):147–57. https://doi.org/10.1016/s0092-8674(00)81010-7.
Abraham S, Yeo M, Montero-Balaguer M, Paterson H, Dejana E, Marshall CJ, et al. VE-cadherin-mediated cell-cell interaction suppresses sprouting via signaling to MLC2 phosphorylation. Curr Biol. 2009;19(8):668–74. https://doi.org/10.1016/j.cub.2009.02.057.
Gaengel K, Niaudet C, Hagikura K, Lavina B, Muhl L, Hofmann JJ, et al. The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2. Dev Cell. 2012;23(3):587–99. https://doi.org/10.1016/j.devcel.2012.08.005.
Skurk C, Maatz H, Rocnik E, Bialik A, Force T, Walsh K. Glycogen-synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells. Circ Res. 2005;96(3):308–18. https://doi.org/10.1161/01.RES.0000156273.30274.f7.
Stenkvist B. Cardenolides and cancer. Anti-Cancer Drugs. 2001;12(7):635–8.
Gupta RS, Chopra A, Stetsko DK. Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis). J Cell Physiol. 1986;127(2):197–206. https://doi.org/10.1002/jcp.1041270202.
Mijatovic T, Dufrasne F, Kiss R. Cardiotonic steroids-mediated targeting of the Na(+)/K(+)-ATPase to combat chemoresistant cancers. Curr Med Chem. 2012;19(5):627–46.
Kim WK, Bach DH, Ryu HW, Oh J, Park HJ, Hong JY, et al. Cytotoxic activities of Telectadium dongnaiense and its constituents by inhibition of the Wnt/beta-catenin signaling pathway. Phytomedicine. 2017;34:136–42. https://doi.org/10.1016/j.phymed.2017.08.008.
Trenti A, Zulato E, Pasqualini L, Indraccolo S, Bolego C, Trevisi L. Therapeutic concentrations of digitoxin inhibit endothelial focal adhesion kinase and angiogenesis induced by different growth factors. Br J Pharmacol. 2017;174(18):3094–106. https://doi.org/10.1111/bph.13944.
Zhang RR, Tian HY, Tan YF, Chung TY, Sun XH, Xia X, et al. Structures, chemotaxonomic significance, cytotoxic and Na(+),K(+)-ATPase inhibitory activities of new cardenolides from Asclepias curassavica. Org Biomol Chem. 2014;12(44):8919–29. https://doi.org/10.1039/c4ob01545b.
The authors would like to thank Fatemeh Radmanesh, Mohammad Rezaei, and Saeed Yakhkeshi for their assistance. We would like to thank Prof. Hossein Baharvand for his kind advices.
Availability of data and material
The data are available upon request.
This work was supported financially by Research and Technology Council of Royan Institute.
Conflicts of interest/competing interests
The authors declared no conflicts of interest.
All animal studies were performed in accordance with guidelines approved by the Ethics Committee of Royan Institute in conformity with the NIH Guide for the Care and Use of Laboratory Animals.
Consent to participate
Consent for publication
Written informed consent for publication was obtained and attached.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Hosseini, M., Ayyari, M., Meyfour, A. et al. Cardenolide-rich fraction of Pergularia tomentosa as a novel Antiangiogenic agent mainly targeting endothelial cell migration. DARU J Pharm Sci (2020). https://doi.org/10.1007/s40199-020-00356-7
- Pergularia tomentosa